大摩:料美國需求復甦及中國生豬價格回升 予萬洲國際(0288.HK)“增持”評級
大摩發研報吿,指內地及美國生豬價格波動對生豬養殖行業帶來壓力。該行料美國需求復甦及中國生豬價格回升,為萬洲帶來逐漸正面環境。該行恢復覆蓋萬洲予“增持”評級,目標價7.8港元。萬洲國際(0288.HK)將於今日(26日)收市後公佈首三季業績。
大摩指出,倘疫情持續放緩,將為萬洲作為增長引擎的美國業務帶來增長機會,因10月起餐廳到店業務改善以及持續經濟重啟。另外,報吿下調今年生豬價格預測,以反映第三季跌幅大過預期,料明年生豬價格反彈。該行料下游業務將受惠生豬養殖成本下降。報吿維持中糧家佳康(1610.HK)“與大市同步”評級,目標價由2.6港元升至2.9港元,認為現時估值合理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.